Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BIOGENERA SpA logo — La piattaforma biotecnologica unica e brevettata per generar...

BIOGENERA SpA

La piattaforma biotecnologica unica e brevettata per generare farmaci personalizzati a DNA per patologie incurabili

Founded 2008 Italy Italy 19 employees Equity Crowdfunding Total: $4.49M Biopharma, Biotechnology +2

General Information

Company Name BIOGENERA SpA
Founded Year 2008
Location Italy Italy +1
Employees 19
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Equity Crowdfunding
Social

Get notified when BIOGENERA SpA moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BIOGENERA SpA

BIOGENERA SpA is a biotechnology pharmaceutical company founded in 2008 and based in Bologna, Italy. The company's slogan "La piattaforma biotecnologica unica e brevettata per generare farmaci personalizzati a DNA per patologie incurabili" highlights its unique patented biotechnological platform for generating personalized DNA-based drugs for incurable pathologies. BIOGENERA leverages a multidisciplinary team of researchers and strategic partnerships with the University of Bologna, among others, to drive innovation in the biopharma, biotechnology, healthcare, and pharmaceutical industries. Its last investment of €2.80M through Equity Crowdfunding came from Proximity Capital on 20 October 2021. The company's overarching mission is to develop new treatments for currently incurable diseases, with an emphasis on pediatric tumors. Powered by the exclusive MyGeneraTM platform, BIOGENERA can rapidly identify and develop patient-specific medicines targeting single mutated genes, addressing the root causes of pathologies. This innovative approach enables the company to create gene-specific molecules tailored to individual DNA, paving the way for personalized DNA cures. Overall, BIOGENERA SpA's unique focus on personalized DNA-based medicines and its recent sizable investment from Proximity Capital positions it as an innovative player to watch in the biotechnology pharmaceutical sector.

Taxonomy: pharmaceuticals, DNA-based medicine, personalized medicine, University partnerships, pediatric tumors, gene-specific therapy, innovation, biotechnological medicines, genetic medicine, multidisciplinary research, medical breakthroughs

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Equity Crowdfunding •••••• 1
Investor
20 Oct 2021
Equity Crowdfunding •••••• - 27 Jul 2021
Seed Round •••••• 1
Investor
01 Jun 2013
Seed Round •••••• 1 •••• •••• 01 Mar 2009

BIOGENERA SpA Alternatives & Competitors

BIOGENERA SpA vs
Candioli Pharma
Candioli Pharma Italy

Developing Excellence since 1882

137 employees
Manufacturing, Pharmaceutical

FAQ About BIOGENERA SpA

La piattaforma biotecnologica unica e brevettata per generare farmaci personalizzati a DNA per patologie incurabili
BIOGENERA SpA was founded in 2008.
BIOGENERA SpA is headquartered in Italy.
BIOGENERA SpA operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
BIOGENERA SpA has approximately 19 employees.
BIOGENERA SpA has completed 4 funding rounds, raising a total of $4.49M. The latest funding stage is Equity Crowdfunding.
Top alternatives and competitors to BIOGENERA SpA include Candioli Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BIOGENERA SpA and Candioli Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BIOGENERA SpA and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes